Company Active LTD

Company profile

Bedfont Scientific Limited

UK company 01289798, incorporated on 8 December 1976.

Gastrolyzer by Bedfont - Helps to detect gastrointestinal disorders

The Gastrolyzer products by Bedfont Scientific Ltd. are Hydrogen and Methane breath testing devices helping to detect gastrointestinal disorders.

Company number
01289798
Incorporated
8 Dec 1976
Companies House status
Active

Company identity

Founded / incorporated
8 December 1976

Company number 01289798

Verify at Companies House
Legal name
BEDFONT SCIENTIFIC LIMITED
Company type
Private Limited Company
Region
South East England
Registered address
STATION YARD
STATION ROAD
HARRIETSHAM
KENT
ME17 1JA
Insolvency history
No

Latest accounts

Financial period: 1 Oct 2023 to 30 Sep 2024

FULLACCOUNTS
Turnover
Unknown
Profit / Loss
£1,261,021
Employees
55

Company events

Reference milestones and recent Companies House filing stream events.

5 events
30 Sep
2027

Accounts due

Accounts Due

Next accounts due date

14 Dec
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Nov
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

30 Sep
2025

Accounts filed

Accounts

Last accounts made up date

08 Dec
1976

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards
First funded
2009
Funded years
2009, 2025
Age at first award
32 years

Projects

2025 Collaborative R&D Lead participant

An innovative device and app using smartphone technology and improved componentry to provide real-time, at-home asthma management and save lives

1 Mar 2025 to 31 Dec 2025

Awarded
£281,953
Total cost £469,922

Bedfont is a UK-based medical device SME established in 1976\. The project is led by an extensive, multidiscipline team with a combined experience in breath analysis of over 50 years. Poor asthma management contributes to 250K preventable deaths globally each year -- around 60% of asthma deaths. It also leads to $100B in healthcare and economic costs, 136...

2009 Legacy RDA Grant for R&D Lead participant

Ammonia Projects

1 Dec 2009 to 31 Mar 2011

Awarded
£82,800
Total cost £207,000

Ammonia given off on exhaled breath can be used as an indicator of Helicobacter Pylori (HPylori) infection. H-Pylori is one of the most common bacterial pathogens in humans and is now recognised as a worldwide problem. It causes chronic gastritis, peptic ulcer disease, and lymphoproliferative disorders and is a major risk factor for gastric cancer1• There...

Product types

Collaborative R&D Legacy RDA Grant for R&D